These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10374881)

  • 1. APS, an adaptor protein containing Pleckstrin homology (PH) and Src homology-2 (SH2) domains inhibits the JAK-STAT pathway in collaboration with c-Cbl.
    Wakioka T; Sasaki A; Mitsui K; Yokouchi M; Inoue A; Komiya S; Yoshimura A
    Leukemia; 1999 May; 13(5):760-7. PubMed ID: 10374881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis.
    Yokouchi M; Wakioka T; Sakamoto H; Yasukawa H; Ohtsuka S; Sasaki A; Ohtsubo M; Valius M; Inoue A; Komiya S; Yoshimura A
    Oncogene; 1999 Jan; 18(3):759-67. PubMed ID: 9989826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W; Zhang J; Lodish HF
    Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
    Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
    Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
    Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of c-Cbl leads to enhanced G-CSF Jak-STAT signaling without increased cell proliferation.
    Wang L; Rudert WA; Loutaev I; Roginskaya V; Corey SJ
    Oncogene; 2002 Aug; 21(34):5346-55. PubMed ID: 12149655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new protein containing an SH2 domain that inhibits JAK kinases.
    Endo TA; Masuhara M; Yokouchi M; Suzuki R; Sakamoto H; Mitsui K; Matsumoto A; Tanimura S; Ohtsubo M; Misawa H; Miyazaki T; Leonor N; Taniguchi T; Fujita T; Kanakura Y; Komiya S; Yoshimura A
    Nature; 1997 Jun; 387(6636):921-4. PubMed ID: 9202126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cbl functions downstream of Src kinases in Fc gamma RI signaling in primary human macrophages.
    Erdreich-Epstein A; Liu M; Kant AM; Izadi KD; Nolta JA; Durden DL
    J Leukoc Biol; 1999 Apr; 65(4):523-34. PubMed ID: 10204582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The signal transduction through Grb2/Ash in hematopoietic cells.
    Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H
    Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
    Arcasoy MO; Harris KW; Forget BG
    Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
    Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
    Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2, and Cbl in hematopoietic cells.
    Chin H; Saito T; Arai A; Yamamoto K; Kamiyama R; Miyasaka N; Miura O
    Biochem Biophys Res Commun; 1997 Oct; 239(2):412-7. PubMed ID: 9344843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common epitope is shared by activated signal transducer and activator of transcription-5 (STAT5) and the phosphorylated erythropoietin receptor: implications for the docking model of STAT activation.
    Barber DL; Beattie BK; Mason JM; Nguyen MH; Yoakim M; Neel BG; D'Andrea AD; Frank DA
    Blood; 2001 Apr; 97(8):2230-7. PubMed ID: 11290583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional effects of APS and SH2-B on insulin receptor signalling.
    Ahmed Z; Pillay TS
    Biochem Soc Trans; 2001 Aug; 29(Pt 4):529-34. PubMed ID: 11498022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta.
    Rui L; Gunter DR; Herrington J; Carter-Su C
    Mol Cell Biol; 2000 May; 20(9):3168-77. PubMed ID: 10757801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of APS, an adaptor molecule containing PH and SH2 domains that is tyrosine phosphorylated upon B-cell receptor stimulation.
    Yokouchi M; Suzuki R; Masuhara M; Komiya S; Inoue A; Yoshimura A
    Oncogene; 1997 Jul; 15(1):7-15. PubMed ID: 9233773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription.
    Goh EL; Zhu T; Leong WY; Lobie PE
    Endocrinology; 2002 Sep; 143(9):3590-603. PubMed ID: 12193575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of JAK2 and STAT5 with erythropoietin receptors. Role of receptor phosphorylation in erythropoietin signal transduction.
    Sawyer ST; Penta K
    J Biol Chem; 1996 Dec; 271(50):32430-7. PubMed ID: 8943308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation.
    Endo T; Sasaki A; Minoguchi M; Joo A; Yoshimura A
    J Biochem; 2003 Jan; 133(1):109-13. PubMed ID: 12761205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.